Status:
COMPLETED
Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Medication Understanding
Diabetes
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
The overall objective of this study is to test the efficacy of an evidence-based, enhanced Rx container label design to improve Spanish speaking patients' understanding of instructions for use.
Detailed Description
The investigators will conduct a randomized controlled trial (N=960) to evaluate the efficacy of the enhanced Rx container label to improve, Spanish speaking, diabetic and/or hypertensive patients' un...
Eligibility Criteria
Inclusion
- Diagnosis of Type II diabetes or hypertension in their medical chart
- Spanish speaking
- 30 years or older
Exclusion
- Uncorrectable hearing or visual impairment.
- Too ill to participate
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT01200849
Start Date
October 1 2010
End Date
January 1 2014
Last Update
November 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611